Bridgeway Capital Management’s scPharmaceuticals SCPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$259K	Hold	67,900	–	–	0.01%	901
2025 Q1	$179K	Sell	67,900 -34,400	-34%	-$90.5K	﹤0.01%	948
2024 Q4	$362K	Sell	102,300 -37,600	-27%	-$133K	0.01%	881
2024 Q3	$638K	Sell	139,900 -49,100	-26%	-$224K	0.01%	804
2024 Q2	$822K	Hold	189,000	–	–	0.02%	742
2024 Q1	$949K	Buy	189,000 +45,000	+31%	+$226K	0.02%	757
2023 Q4	$903K	Hold	144,000	–	–	0.02%	782
2023 Q3	$1.03M	Hold	144,000	–	–	0.02%	706
2023 Q2	$1.47M	Sell	144,000 -48,200	-25%	-$491K	0.04%	639
2023 Q1	$1.74M	Hold	192,200	–	–	0.05%	575
2022 Q4	$1.38M	Buy	192,200 +60,000	+45%	+$430K	0.04%	669
2022 Q3	$862K	Hold	132,200	–	–	0.02%	765
2022 Q2	$637K	Hold	132,200	–	–	0.01%	826
2022 Q1	$751K	Hold	132,200	–	–	0.01%	846
2021 Q4	$664K	Hold	132,200	–	–	0.01%	907
2021 Q3	$879K	Buy	132,200 +30,000	+29%	+$199K	0.02%	863
2021 Q2	$624K	Sell	102,200 -500	-0.5%	-$3.05K	0.01%	1007
2021 Q1	$683K	Buy	+102,700	New	+$683K	0.01%	1008
2020 Q4	–	Sell	-39,200	Closed	-$292K	–	1362
2020 Q3	$292K	Hold	39,200	–	–	0.01%	1080
2020 Q2	$289K	Sell	39,200 -25,000	-39%	-$184K	0.01%	1053
2020 Q1	$475K	Hold	64,200	–	–	0.01%	781
2019 Q4	$363K	Buy	64,200 +2,700	+4%	+$15.3K	﹤0.01%	1077
2019 Q3	$364K	Hold	61,500	–	–	0.01%	1049
2019 Q2	$196K	Sell	61,500 -2,800	-4%	-$8.92K	﹤0.01%	1183
2019 Q1	$193K	Buy	64,300 +50,000	+350%	+$150K	﹤0.01%	1228
2018 Q4	$54K	Sell	14,300 -55,200	-79%	-$208K	﹤0.01%	1335
2018 Q3	$408K	Hold	69,500	–	–	﹤0.01%	1189
2018 Q2	$393K	Hold	69,500	–	–	﹤0.01%	1197
2018 Q1	$862K	Buy	+69,500	New	+$862K	0.01%	899